Molecular and Cellular Biochemistry

, Volume 337, Issue 1–2, pp 307–315 | Cite as

Dietary fat and apolipoprotein genotypes modulate plasma lipoprotein levels in Brazilian elderly women

  • R. S. Paula
  • V. C. Souza
  • A. L. Benedet
  • E. R. Souza
  • J. O. Toledo
  • C. F. Moraes
  • L. Gomes
  • C. S. Alho
  • C. Córdova
  • O. T. Nóbrega


Studies show that genetic polymorphisms in apolipoproteins, which are in charge of lipid transport, predispose to atherogenic dyslipidemia. This study aimed to investigate the impact of apolipoprotein E, A5, and B genotypes and dietary intake on lipid profile in a sample of elderly women in Brazil. Two hundred and fifty-two women (60 years or older) living in the outskirts of the Brazilian Federal District underwent clinical and laboratory assessments to characterize glycemic and lipidemic variables, and also to exclude confounding factors (smoking, drinking, hormone replacement, cognitive impairment, physical activity). Three-day food records were used to determine usual dietary intake, whereas genotypic evaluations were in accordance to established methodologies. Genotype frequencies were consistent with the Hardy–Weinberg equilibrium. Prior to adjustment, individuals carrying the ε2 allele showed higher serum levels of triglycerides (P < 0.05) and VLDL (P < 0.005) compared to ε4 carriers, whereas LDL levels were considerably elevated in ε4 compared to ε2 carriers. In the presence of high intake of total fat or a low ratio of polyunsaturated to saturated fatty acid, ε4 carriers lost protection against hypertriglyceridemia. There was no association of the apolipoprotein A5 and B genotypes with lipidemic levels independently of the fat intake regimen. Results are suggestive of a dysbetalipoproteinemic-like phenotype in postmenopausal women, with remarkable gene–diet interaction.


Hypertriglyceridemia Dysbetalipoproteinemia Genetic polymorphism Food intake Fatty acids Gender Older adult 



The authors thank dieticians Cristiane Urcina Joanna Oliveira Lima, Érika Beatriz Lopes Tavares, Fabíola Reis Sousa, Fernanda Cristina de Jesus Colares-Bento, and Sarah Ricardo Peres da Silveira for gathering nutritional data and assuring adherence to the food registration procedure. Research supported by the National Council for Scientific and Technological Development—CNPq (Grants 484318/2006-3 and 402699/2007-6), by the Federal District Foundation for Research Development—FAPDF (Grants 193.000.309/2007 and 193.000.449/2008) and by the University of Brasília—UnB (DPP/UnB Grant # 01/2009). R.S. Paula received a fellowship from CAPES, and V.C. Sousa received a fellowship from UCB.


  1. 1.
    Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507–537CrossRefPubMedGoogle Scholar
  2. 2.
    Ribalta J, Vallve JC, Girona J, Masana L (2003) Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease. Curr Opin Clin Nutr Metab Care 6:177–187CrossRefPubMedGoogle Scholar
  3. 3.
    Davignon J, Cohn JS, Mabile L, Bernier L (1999) Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta 286:115–143CrossRefPubMedGoogle Scholar
  4. 4.
    Dallongeville J, Lussier-Cacan S, Davignon J (1992) Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 33:447–454PubMedGoogle Scholar
  5. 5.
    Song Y, Stampfer MJ, Liu S (2004) Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141:137–147PubMedGoogle Scholar
  6. 6.
    Greenow K, Pearce NJ, Ramji DP (2005) The key role of apolipoprotein E in atherosclerosis. J Mol Med 83:329–342CrossRefPubMedGoogle Scholar
  7. 7.
    Hsu LA, Ko YL, Chang CJ, Hu CF, Wu S, Teng MS, Wang CL, Ho WJ, Ko YS, Hsu TS, Lee YS (2006) Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 185:143–149CrossRefPubMedGoogle Scholar
  8. 8.
    Szalai C, Keszei M, Duba J, Prohaszka Z, Kozma GT, Csaszar A, Balogh S, Almassy Z, Fust G, Czinner A (2004) Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 173:109–114CrossRefPubMedGoogle Scholar
  9. 9.
    Lai CQ, Demissie S, Cupples LA, Zhu Y, Adiconis X, Parnell LD, Corella D, Ordovas JM (2004) Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 45:2096–2105CrossRefPubMedGoogle Scholar
  10. 10.
    Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169–173CrossRefPubMedGoogle Scholar
  11. 11.
    Schaap FG, Rensen PC, Voshol PJ, Vrins C, van der Vliet HN, Chamuleau RA, Havekes LM, Groen AK, van Dijk KW (2004) ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 279:27941–27947CrossRefPubMedGoogle Scholar
  12. 12.
    Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J (2005) Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 280:21553–21560CrossRefPubMedGoogle Scholar
  13. 13.
    Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Humphries SE (1991) Variation of apolipoprotein B gene is associated with myocardial infarction and lipoprotein levels in Danes. Atherosclerosis 89:69–81CrossRefPubMedGoogle Scholar
  14. 14.
    Peacock R, Dunning A, Hamsten A, Tornvall P, Humphries S, Talmud P (1992) Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: a study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 92:151–164CrossRefPubMedGoogle Scholar
  15. 15.
    Cavalli SA, Hirata MH, Salazar LA, Diament J, Forti N, Giannini SD, Nakandakare ER, Bertolami MC, Hirata RD (2000) Apolipoprotein B gene polymorphisms: prevalence and impact on serum lipid concentrations in hypercholesterolemic individuals from Brazil. Clin Chim Acta 302:189–203CrossRefPubMedGoogle Scholar
  16. 16.
    Benn M (2009) Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review. Atherosclerosis 206:17–30Google Scholar
  17. 17.
    Scartezini M, Zago MA, Chautard-Freire-Maia EA, Pazin-Filho A, Marin-Neto JA, Hotta JK, Nascimento AJ, Dos-Santos JE (2003) The XX/E+E+ genotype of the XbaI/EcoRI polymorphisms of the apolipoprotein B gene as a marker of coronary artery disease in a Brazilian sample. Braz J Med Biol Res 36:369–375CrossRefPubMedGoogle Scholar
  18. 18.
    Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y, Parnell LD, Tucker KL, Ordovas JM (2006) Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation 113:2062–2070CrossRefPubMedGoogle Scholar
  19. 19.
    Mendes-Lana A, Pena GG, Freitas SN, Lima AA, Nicolato RL, Nascimento-Neto RM, Machado-Coelho GL, Freitas RN (2007) Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto study. Braz J Med Biol Res 40:49–56CrossRefPubMedGoogle Scholar
  20. 20.
    Fuzikawa AK, Peixoto SV, Taufer M, Moriguchi EH, Lima-Costa MF (2008) Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambui Health Aging Study (BHAS). Braz J Med Biol Res 41:89–94PubMedGoogle Scholar
  21. 21.
    Tonet AC, Karnikowski M, Moraes CF, Gomes L, Karnikowski MG, Cordova C, Nobrega OT (2008) Association between the −174 G/C promoter polymorphism of the interleukin-6 gene and cardiovascular disease risk factors in Brazilian older women. Braz J Med Biol Res 41:47–53CrossRefPubMedGoogle Scholar
  22. 22.
    Moraes CF, Souza ER, Souza VC, Medeiros EF, Goncalves TF, Toledo JO, Karnikowski M, Gomes L, Karnikowski MG, Cordova C, Nobrega OT (2008) A common polymorphism in the renin angiotensin system is associated with differential outcome of antihypertensive pharmacotherapy prescribed to Brazilian older women. Clin Chim Acta 396:70–75CrossRefPubMedGoogle Scholar
  23. 23.
    Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMedGoogle Scholar
  24. 24.
    Brekke MJ, Brekke ML, Quiter ES, Peters JR, Mullis RM, Hunninghake DB (1992) Appropriate days for measuring intake of dietary fat and cholesterol. Ann Nutr Metab 36:318–327CrossRefPubMedGoogle Scholar
  25. 25.
    Stuff JE, Garza C, Smith EO, Nichols BL, Montandon CM (1983) A comparison of dietary methods in nutritional studies. Am J Clin Nutr 37:300–306PubMedGoogle Scholar
  26. 26.
    Luhrmann PM, Herbert BM, Gaster C, Neuhauser-Berthold M (1999) Validation of a self-administered 3-day estimated dietary record for use in the elderly. Eur J Nutr 38:235–240CrossRefPubMedGoogle Scholar
  27. 27.
    Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMedGoogle Scholar
  28. 28.
    Castro-Costa E, Fuzikawa C, Uchoa E, Firmo JO, Lima-Costa MF (2008) Norms for the mini-mental state examination: adjustment of the cut-off point in population-based studies (evidences from the Bambui health aging study). Arq Neuropsiquiatr 66:524–528PubMedGoogle Scholar
  29. 29.
    Philippi ST (2002) Tabela de composição de alimentos: suporte para decisão nutricional. Coronário, São Paulo, p 135Google Scholar
  30. 30.
    Donohoe GG, Salomaki A, Lehtimaki T, Pulkki K, Kairisto V (1999) Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clin Chem 45:143–146PubMedGoogle Scholar
  31. 31.
    Renges HH, Peacock R, Dunning AM, Talmud P, Humphries SE (1992) Genetic relationship between the 3′-VNTR and diallelic apolipoprotein B gene polymorphisms: haplotype analysis in individuals of European and south Asian origin. Ann Hum Genet 56:11–33CrossRefPubMedGoogle Scholar
  32. 32.
    Utermann G, Hees M, Steinmetz A (1977) Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 269:604–607CrossRefPubMedGoogle Scholar
  33. 33.
    Rall SC Jr, Weisgraber KH, Innerarity TL, Mahley RW (1982) Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci USA 79:4696–4700CrossRefPubMedGoogle Scholar
  34. 34.
    Cohen J (1992) A power primer. Psychol Bull 112:155–159CrossRefPubMedGoogle Scholar
  35. 35.
    Galetto R, Albajar M, Polanco JI, Zakin MM, Rodriguez-Rey JC (2001) Identification of a peroxisome-proliferator-activated-receptor response element in the apolipoprotein E gene control region. Biochem J 357:521–527CrossRefPubMedGoogle Scholar
  36. 36.
    Hopkins PN, Heiss G, Ellison RC, Province MA, Pankow JS, Eckfeldt JH, Hunt SC (2003) Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 108:519–523CrossRefPubMedGoogle Scholar
  37. 37.
    Hopkins PN, Wu LL, Hunt SC, Brinton EA (2005) Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol 45:1003–1012CrossRefPubMedGoogle Scholar
  38. 38.
    Institute of Medicine (1998) Dietary reference intakes: a risk assessment model for establishing upper intake levels for nutrients. Institute of Medicine, Washington, DCGoogle Scholar
  39. 39.
    Horejsi B, Ceska R (2000) Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis. Physiol Res 49(Suppl 1):S63–S69PubMedGoogle Scholar
  40. 40.
    Srivastava RA, Srivastava N, Averna M, Lin RC, Korach KS, Lubahn DB, Schonfeld G (1997) Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. J Biol Chem 272:33360–33366CrossRefPubMedGoogle Scholar
  41. 41.
    Mahley RW, Huang Y, Rall SC Jr (1999) Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res 40:1933–1949PubMedGoogle Scholar
  42. 42.
    Lopez D, Abisambra Socarras JF, Bedi M, Ness GC (2007) Activation of the hepatic LDL receptor promoter by thyroid hormone. Biochim Biophys Acta 1771:1216–1225PubMedGoogle Scholar
  43. 43.
    Pimenta JR, Zuccherato LW, Debes AA, Maselli L, Soares RP, Moura-Neto RS, Rocha J, Bydlowski SP, Pena SD (2006) Color and genomic ancestry in Brazilians: a study with forensic microsatellites. Hum Hered 62:190–195CrossRefPubMedGoogle Scholar
  44. 44.
    Nobrega OT, Faleiros VP, Telles JL (2009) Gerontology in the developing Brazil: achievements and challenges in public policies. Geriatr Gerontol Int 9:135–139CrossRefPubMedGoogle Scholar
  45. 45.
    Karnikowski M, Cordova C, Oliveira RJ, Karnikowski MG, Nobrega OT (2007) Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults. Sao Paulo Med J 125:333–337CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  • R. S. Paula
    • 1
  • V. C. Souza
    • 1
  • A. L. Benedet
    • 2
  • E. R. Souza
    • 1
  • J. O. Toledo
    • 1
  • C. F. Moraes
    • 2
    • 3
  • L. Gomes
    • 1
    • 3
  • C. S. Alho
    • 4
  • C. Córdova
    • 5
  • O. T. Nóbrega
    • 2
  1. 1.Postgraduate Program in GerontologyCatholic University of Brasília (UCB)TaguatingaBrazil
  2. 2.Postgraduate Program in Medical SciencesUniversity of Brasília (UnB)Plano PilotoBrazil
  3. 3.Geriatrics ServiceHospital of the Catholic University of Brasília (HUCB)BrasíliaBrazil
  4. 4.Biosciences FacultyPontifical Catholic University of Rio Grande do Sul (PUCRS)Porto AlegreBrazil
  5. 5.Postgraduate Program in Physical EducationCatholic University of Brasília (UCB)BrasíliaBrazil

Personalised recommendations